Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies
- 1Unit of Immune and Infectious Diseases, University Department of Pediatrics (DPUO), Scientific Institute for Research and Healthcare (IRCCS) Childrens' Hospital Bambino Gesù, Rome, Italy
- 2San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, Italy
- 3Pediatric Immunohematology and Bone Marrow Transplantation Unit, Scientific Institute for Research and Healthcare (IRCCS) San Raffaele Scientific Institute, Milan, Italy
- 4Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy
- 5Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
- 6Vita Salute San Raffaele University, Milan, Italy
- 7Center for Translational Genomics and BioInformatics, San Raffaele Scientific Institute, Milan, Italy
- 8Division of Immunology and Rheumatology, Department of Paediatric Infectious Diseases, Regina Margherita Children's Hospital, University of Turin, Turin, Italy
- 9Pediatric Immunology, Department of Health Sciences, University of Florence, Florence, Italy
- 10Meyer Children's Hospital, Florence, Italy
- 11Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy
- 12Department of Molecular and Translational Medicine, A. Nocivelli Institute for Molecular Medicine, University of Brescia, Brescia, Italy
- 13Unit of Medical Genetics, St. Orsola-Malpighi University Hospital, University of Bologna, Bologna, Italy
- 14Division of Immunology Transplantation and Infectious Diseases (DITID), Diabetes Research Institute (DRI) IRCCS San Raffaele Scientific Institute, Milan, Italy
- 15Pediatric Department, San Raffaele Scientific Institute, Milan, Italy
- 16Department of Onco-Hematology and Cell and Gene Therapy, Scientific Institute for Research and Healthcare (IRCCS) Childrens' Hospital Bambino Gesù, Rome, Italy
- 17Paediatric Hematology-Oncology, “Ospedale della Donna e del Bambino”, Verona, Italy
- 18Center for Autoinflammatory Diseases and Immunodeficiencies, IRCCS Giannina Gaslini, Genoa, Italy
- 19Department of Pediatric Hematology and Oncology, “ARNAS Civico Di Cristina Benfratelli” Hospital, Palermo, Italy
- 20Pediatric Immunopathology and Allergology Unit, University of Rome Tor Vergata Policlinico Tor Vergata, Rome, Italy
- 21Milan Unit, National Research Council (CNR) Institute for Genetic and Biomedical Research (IRGB), Milan, Italy
- 22Humanitas Clinical and Research Institute, Rozzano, Italy
- 23Department of Pediatric Hematology and Oncology, Scientific Institute for Research and Healthcare (IRCCS) Childrens' Hospital Bambino Gesù, University of Rome La Sapienza, Rome, Italy
A Corrigendum on
Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies
by Cifaldi, C., Brigida, I., Barzaghi, F., Zoccolillo, M., Ferradini, V., Petricone, D., et al. (2019). Front. Immunol. 10:316. doi: 10.3389/fimmu.2019.00316
In the published article, there was an error in affiliation “18.” Instead of “Pediatric and Rheumatology Unit, Giannina Gaslini Institute, Genoa, Italy,” it should be “Center for Autoinflammatory Diseases and Immunodeficiencies, IRCCS Giannina Gaslini, Genoa, Italy.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: primary immunodeficiencies, Next Generation Sequencing, gene panels, Ion Torrent, Haloplex
Citation: Cifaldi C, Brigida I, Barzaghi F, Zoccolillo M, Ferradini V, Petricone D, Cicalese MP, Lazarevic D, Cittaro D, Omrani M, Attardi E, Conti F, Scarselli A, Chiriaco M, Di Cesare S, Licciardi F, Davide M, Ferrua F, Canessa C, Pignata C, Giliani S, Ferrari S, Fousteri G, Barera G, Merli P, Palma P, Cesaro S, Gattorno M, Trizzino A, Moschese V, Chini L, Villa A, Azzari C, Finocchi A, Locatelli F, Rossi P, Sangiuolo F, Aiuti A, Cancrini C and Di Matteo G (2019) Corrigendum: Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies. Front. Immunol. 10:1184. doi: 10.3389/fimmu.2019.01184
Received: 08 May 2019; Accepted: 09 May 2019;
Published: 31 May 2019.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2019 Cifaldi, Brigida, Barzaghi, Zoccolillo, Ferradini, Petricone, Cicalese, Lazarevic, Cittaro, Omrani, Attardi, Conti, Scarselli, Chiriaco, Di Cesare, Licciardi, Davide, Ferrua, Canessa, Pignata, Giliani, Ferrari, Fousteri, Barera, Merli, Palma, Cesaro, Gattorno, Trizzino, Moschese, Chini, Villa, Azzari, Finocchi, Locatelli, Rossi, Sangiuolo, Aiuti, Cancrini and Di Matteo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Alessandro Aiuti, aiuti.alessandro@hsr.it; Caterina Cancrini, cancrini@med.uniroma2.it
†These authors have contributed equally to this work
‡These authors shared last authorship